文献速递临床生化质量管理与危急值

多仪器临床化学实验室结果的定期可比性验证与室内协调

Periodic Comparability Verification and Within-Laboratory Harmonization of Clinical Chemistry Laboratory Results at a Large Healthcare Center With Multiple Instruments.
PubMed 文献 · Ann Lab Med · 2022-01-01

该研究在拥有五台不同厂商临床化学仪器的大型医疗中心,开发了一种简便可行的定期可比性验证方法,使用混合残余患者样本进行每周验证。2015至2019年间对12项临床化学检测获得432次周间仪器间可比性验证结果,约58%的结果因不可比而经转换因子转换后报告。转换后预期平均绝对百分比偏倚和不可比结果百分比均大幅降低,所有分析物的仪器间CV也显著降低。

要点

  • 使用混合残余血清每周验证多仪器间可比性,方法简便低耗。
  • 约58%验证结果因超出允许范围需经转换因子校正后报告。
  • 转换后偏倚和仪器间CV显著降低,维持了五年室内可比性。

核心结论

  • 使用混合残余血清的频繁低劳动强度定期可比性验证方法,可在五年内维持多仪器临床化学检测的室内可比性。

研究设计与样本

  • 研究于2015至2019年评估五台临床化学仪器(Beckman Coulter AU5800、Abbott Architect Ci16000、两台Siemens Vista 1500和Ortho Vitros 5600)对12项临床化学检测的可比性,使用混合残余患者样本进行每周验证,共获得432次周间仪器间可比性验证结果。

主要发现

  • 约58%的结果因不可比验证而经转换因子转换后报告给临床医生。
  • 转换后预期平均绝对百分比偏倚和不可比结果百分比均远低于转换前测量数据。
  • 所有分析物转换后不可比和转换结果的仪器间CV均远低于转换前测量数据。

关键数值与推荐

  • 转换因子通过简化比较获得的线性回归方程确定。
  • 任何仪器结果与比较仪器(AU5800)结果相比超出允许验证范围时,乘以转换因子后报告。

临床怎么用

  • 大型检测机构可使用混合残余血清进行频繁低劳动强度的定期可比性验证,并对超出允许范围的仪器结果应用转换因子后报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Results from laboratories using multiple instruments should be standardized or harmonized and comparability-verified for consistent quality control. We developed a simple frequent comparability verification methodology applicable to large healthcare centers using multiple clinical chemistry instruments from different manufacturers. METHODS: Comparability of five clinical chemistry instruments (Beckman Coulter AU5800, Abbott Architect Ci16000, two Siemens Vista 1500, and Ortho Vitros 5600) was evaluated from 2015 to 2019 for 12 clinical chemistry measurements. Pooled residual patient samples were used for weekly verifications. Results from any instrument exceeding the allowable verification range versus the results from the comparative instrument (AU5800) were reported to clinicians after being multiplied by conversion factors that were determined via a linear regression equation obtained from simplified comparison. RESULTS: Over the five-year study period, 432 weekly inter-instrument comparability verification results were obtained. Approximately 58% of results were converted due to non-comparable verification. Expected average absolute percent bias and percentage of non-comparable results for non-converted and converted results after conversion action were much lower than those for data measured before conversion action. The inter-instrument CV for both non-converted and converted results after conversion action was much lower than that for measured data before conversion action for all analytes. CONCLUSIONS: We maintained within-laboratory comparability of clinical chemistry tests from multiple instruments for five years using frequent low-labor periodic comparability verification methods from pooled residual sera. This methodology is applicable to large testing facilities using multiple instruments.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Nam Y, Lee JH, Kim SM, et al. Periodic Comparability Verification and Within-Laboratory Harmonization of Clinical Chemistry Laboratory Results at a Large Healthcare Center With Multiple Instruments. Ann Lab Med. 2022. PMID: 34635608. doi:10.3343/alm.2022.42.2.150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。